See also this year's filing and all EDGAR filings for this company.
PDF Report 0001622996_2025_ACRO_Biomedical_CO_LTD.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Liabilities', 'value': 401062, 'size_variable': 'Assets', 'size_value': 14098, 'ratio': 28.4, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001622996')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001622996, ACRO Biomedical CO LTD
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,076 |
| 1 | PropertyPlantAndEquipment | 0 |
| 2 | LeaseAsset | 26,898 |
| 3 | AssetsNonCurrent | 0 |
| 4 | IntangibleAssets | 0 |
| 5 | remainder_Assets | 0 |
| 6 | LiabilitiesCurrent | 326,946 |
| 7 | LiabilitiesNonCurrent | 0 |
| 8 | remainder_Liabilities | 0 |
| 9 | SellingGeneralAndAdministrativeExpense | 37,958 |
| 10 | GeneralAndAdministrativeExpense | 0 |
| 11 | CostOfGoodsAndServicesSold | 0 |
| 12 | DepreciationAndAmortization | 0 |
| 13 | OperatingExpenses | 0 |
| 14 | remainder_Expenses | 4,339 |
| 15 | remainder_Revenues | 0 |
| 16 | remainder_NetIncome | 0 |
| 17 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 31,974 |
| 1 | Liabilities | 326,946 |
| 2 | Expenses | 42,297 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -294,972 |
| 5 | NetIncome | -42,297 |
| 6 | ComprehensiveNetIncome | -42,297 |
| 7 | BaseVar | 200,608 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.85 |
| 9 | EconomicCapitalRatio | 0.477 |
Edgar->Model Mapping
Feature Distribution
Change over Time
